These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 3262229

  • 21. Opioid peptides and immunodysfunction in patients with major depression and anxiety disorders.
    Castilla-Cortázar I, Castilla A, Gurpegui M.
    J Physiol Biochem; 1998 Dec; 54(4):203-15. PubMed ID: 10225412
    [Abstract] [Full Text] [Related]

  • 22. [Pain, anesthesia and drug addiction].
    Carpentier M.
    Rev Stomatol Chir Maxillofac; 1997 Aug; 98(2):120-2. PubMed ID: 9324730
    [Abstract] [Full Text] [Related]

  • 23. Immunological status in heroin addicts: effects of methadone maintenance treatment.
    Lazzarin A, Mella L, Trombini M, Uberti-Foppa C, Franzetti F, Mazzoni G, Galli M.
    Drug Alcohol Depend; 1984 Mar; 13(2):117-23. PubMed ID: 6609805
    [Abstract] [Full Text] [Related]

  • 24. Behavioral activating effects of opiates and opioid peptides.
    Browne RG, Segal DS.
    Biol Psychiatry; 1980 Feb; 15(1):77-86. PubMed ID: 6101965
    [Abstract] [Full Text] [Related]

  • 25. [The effects of plant preparations on cellular functions in body defense].
    Wildfeuer A, Mayerhofer D.
    Arzneimittelforschung; 1994 Mar; 44(3):361-6. PubMed ID: 8192704
    [Abstract] [Full Text] [Related]

  • 26. Drug abuse, innate immunity and hepatitis C virus.
    Zhang T, Li Y, Ho WZ.
    Rev Med Virol; 2006 Mar; 16(5):311-27. PubMed ID: 16933366
    [Abstract] [Full Text] [Related]

  • 27. Buprenorphine and naloxone interactions in methadone maintenance patients.
    Mendelson J, Jones RT, Welm S, Brown J, Batki SL.
    Biol Psychiatry; 1997 Jun 01; 41(11):1095-101. PubMed ID: 9146820
    [Abstract] [Full Text] [Related]

  • 28. Methadone-naloxone in combination for the treatment of heroin addicts.
    Parwatikar SD, Knowles RR.
    Clin Pharmacol Ther; 1973 Jun 01; 14(6):941-8. PubMed ID: 4584151
    [No Abstract] [Full Text] [Related]

  • 29. Clinical studies with naloxone/methadone in a ratio of 1:20.
    Bloom WA, Sudderth EW, Marcello L.
    Proc Natl Conf Methadone Treat; 1973 Jun 01; 2():1342-9. PubMed ID: 4612372
    [No Abstract] [Full Text] [Related]

  • 30. Liver function in drug addicts: hepatitis B markers and cell-mediated immunity.
    Rossi L, Schiavino D, Marra L, Milani A, Bombardieri G, Tempesta E.
    Boll Ist Sieroter Milan; 1985 Jun 01; 64(1):82-5. PubMed ID: 4005062
    [Abstract] [Full Text] [Related]

  • 31. [The effect of discontinuing intravenous opiate injections and methadone treatment on the status of the immune system in narcotic abusers with HIV].
    Radkowski M, Werezyńska T, Kopicz-Kamińska E, Kuligowski S, Slusarczyk J.
    Pol Tyg Lek; 1996 Jun 01; 51(23-26):334-5, 339. PubMed ID: 9273524
    [Abstract] [Full Text] [Related]

  • 32. [Functional disorders of monocytes in heroin addicts].
    Olmos Martínez JM, García Palomo JD, Martínez García J, Jiménez López A.
    Med Clin (Barc); 1986 May 03; 86(17):701-4. PubMed ID: 3736158
    [No Abstract] [Full Text] [Related]

  • 33. Amphetamines in the District of Columbia. III. Stimulant abuse in narcotics addicts in treatment, with an emphasis on phenmetrazine.
    Greene MH, Turner N, DuPont RL.
    Int J Addict; 1974 May 03; 9(5):652-62. PubMed ID: 4155405
    [No Abstract] [Full Text] [Related]

  • 34. Tricyclic antidepressants abuse, with or without benzodiazepines abuse, in former heroin addicts currently in methadone maintenance treatment (MMT).
    Peles E, Schreiber S, Adelson M.
    Eur Neuropsychopharmacol; 2008 Mar 03; 18(3):188-93. PubMed ID: 17997285
    [Abstract] [Full Text] [Related]

  • 35. [Are maintenance substitution practices indicated in the framework of health care of drug addicts?].
    Déglon JJ.
    Ann Med Interne (Paris); 1994 Nov 03; 145 Suppl 3():92-3. PubMed ID: 7880040
    [No Abstract] [Full Text] [Related]

  • 36. Oral motor parafunctions among heavy drug addicts and their effects on signs and symptoms of temporomandibular disorders.
    Winocur E, Gavish A, Volfin G, Halachmi M, Gazit E.
    J Orofac Pain; 2001 Nov 03; 15(1):56-63. PubMed ID: 11889649
    [Abstract] [Full Text] [Related]

  • 37. Over- and underreporting of recent drug use in subjects entering an inpatient detoxification unit.
    Zullino DF, Krenz S, Eap CB, Benguettat D, Khan R.
    Eur J Med Res; 2008 Jan 23; 13(1):15-20. PubMed ID: 18226992
    [Abstract] [Full Text] [Related]

  • 38. [Ambulatory medical treatment of drug dependent patients].
    Gölz J.
    Z Arztl Fortbild (Jena); 1996 Jun 23; 90(4):271-8. PubMed ID: 8928526
    [Abstract] [Full Text] [Related]

  • 39. [Plasma levomethadone level and concomitant use of sedatives in a methadone test program].
    Staak M, Käferstein H, Schumacher B, Sticht G, Iffland R.
    Blutalkohol; 1993 Jul 23; 30(4):232-9. PubMed ID: 8373561
    [Abstract] [Full Text] [Related]

  • 40. The natural history of narcotic drug addiction.
    Vaillant GE.
    Semin Psychiatry; 1970 Nov 23; 2(4):486-98. PubMed ID: 5527413
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.